Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Hypoxia × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Motor Activity 165 Breast Neoplasms 97 Neoplasms 67 Prostatic Neoplasms 25 Fatigue 23 Colorectal Neoplasms 17 Obesity 16 Lung Neoplasms 12 Polycystic Ovary Syndrome 10 Ovarian Neoplasms 10 Colonic Neoplasms 10 Rectal Neoplasms 9 Lymphedema 9 Multiple Myeloma 8 Lymphoma 8 Hematologic Neoplasms 8 Head and Neck Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Pancreatic Neoplasms 7 Cardiotoxicity 7 Carcinoma, Non-Small-Cell Lung 7 Leukemia 6 Insulin Resistance 6 Brain Neoplasms 6 Weight Loss 5 Sarcopenia 5 Esophageal Neoplasms 5 Endometrial Neoplasms 5 Breast Cancer Lymphedema 5 Stomach Neoplasms 4

Interventions

fluoroazomycin arabinoside 3 3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 3 pimonidazole 2 Propofol 2 gadobutrol 1 Sevoflurane 1 Radiotherapy 1 Pancreaticoduodenectomy 1 Oxygen 1 Ketamine 1 Gemcitabine 1 Furosemide 1 Exercise 1 Diagnostic Imaging 1 Blood Specimen Collection 1 Biopsy 1 4-methylbenzenesulfonic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03365076 2023-01-09

EXIPOX

University Hospital of North Norway

Phase NA Terminated

Hypoxia, Motor Activity, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡